Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase
Abroad (travel likely)Recruiting
Conditions
Chronic Myeloid Leukemia, Chronic Phase
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Cagliari - Businco Hospital - Unit of Hematology and Bone Marrow Transplant, Cagliari, Italy
Policlinico Milano, Milan, Italy
Contact: Study coordinator (Alessandra Iurlo, MD) · alessandra.iurlo@policlinico.mi.it · +39 02 5503.1University of Naples Federico II - Unit of Hematology, Naples, Italy
Santa Chiara University Hospital, Pisa, Italy
Federica Ricci, MD (Sub-investigator)Marinunzia Franciosa, MD (Sub-investigator)Ignazio Santo, MD (Sub-investigator)Antonello Di Paolo, MD (Sub-investigator)Francesca Guerrini, BiolD (Sub-investigator)Ospedale S. Eugenio ASL 2 Roma, Roma, Italy
Contact: Study coordinator (Elisabetta Abruzzese, MD) · elisabetta.abruzzese@uniroma2.it · +39 06 51001
Study leads
Sara Galimberti, PhD
Principal Investigator
University of Pisa - Dept. Clinical and Experimental Medicine